Delivery Order SPE2DB25D7056-SPE2DB25FTNHH
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $51,174.08 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30, with a firm fixed price structure and an ultimate completion date of September 16, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,111.32 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,020.92 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, executed on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $37,466.05 firm fixed price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of August 1, 2025. This non-set-aside competitive award was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $14.76K delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) under a firm fixed-price contract, with an ultimate completion date of September 5, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award involved no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $96,220.79 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on June 30, 2025, with an ultimate completion date of July 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,116.14 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025. The contract includes no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 tablets per unit. This firm fixed price delivery order, valued at $16,263.11, represents a non-competitive set-aside award and is scheduled for completion by August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a $37,967.82 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in packages of 30 units. This delivery order, which is a child contract under a larger vehicle, requires completion by September 4, 2025, and was competitively awarded without set-aside provisions. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,051.78 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. The award was made on April 23, 2025, with an ultimate completion date of April 24, 2025, under a firm fixed-price contract structure. This is a competitive award with no set-aside designation, and performance will be executed from the contractor's location in Conshohocken, Pennsylvania. The delivery order is...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTNHHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $34,144.81 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. The award, made on September 24, 2025, with an ultimate completion date of September 25, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The pharmaceutical product being delivered—BIKTARVY (bictegravir/tenofovir alafenamide/emtricitabine)—is an antiretroviral medication used in the treatment of HIV infection. This procurement supports the DLA's medical supply chain mission to provide pharmaceuticals and medical supplies to military healthcare systems and federal medical facilities. AmerisourceBergen Drug Corp's substantial IDC vehicle with DLA positions the company as a critical pharmaceutical distributor for defense medical procurement, enabling rapid fulfillment of varied medication requirements across multiple therapeutic domains in support of military and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.1k | 9/24/25 |